A multi-institutional study to predict the benefits of DEB-TACE and molecular targeted agent sequential therapy in unresectable hepatocellular carcinoma using a radiological-clinical nomogram
Kaicai Liu, Xiaomin Zheng, Dong Lu, Yulin Tan, Changlong Hou, Jiaying Dai, Wanyin Shi, Bo Jiang, Yibin Yao, Yuhe Lu, Qisheng Cao, Ruiwen Chen, Wangao Zhang, Jun Xie, Lei Chen, Mouying Jiang, Zhang Zhang, Lu Liu, Jie Liu, Jianying Li, Wei‐Fu Lv, Xingwang Wu
Topics & Concepts
NomogramMedicineHepatocellular carcinomaReceiver operating characteristicHazard ratioInternal medicineProportional hazards modelTranscatheter arterial chemoembolizationConfidence intervalRadiologyOncologyRetrospective cohort studyLiver cancerStage (stratigraphy)RadiomicsRadiological weaponClinical trialBiologyPaleontologyHepatocellular Carcinoma Treatment and PrognosisCholangiocarcinoma and Gallbladder Cancer StudiesRadiomics and Machine Learning in Medical Imaging